163 related articles for article (PubMed ID: 37924456)
1. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q
Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456
[TBL] [Abstract][Full Text] [Related]
2. CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.
Shang B; Gao A; Pan Y; Zhang G; Tu J; Zhou Y; Yang P; Cao Z; Wei Q; Ding Y; Zhang J; Zhao Y; Zhou Q
Cell Death Dis; 2014 Jun; 5(6):e1285. PubMed ID: 24901056
[TBL] [Abstract][Full Text] [Related]
3. The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic
Yang P; Qiao Y; Liao H; Huang Y; Meng M; Chen Y; Zhou Q
J Breast Cancer; 2023 Apr; 26(2):168-185. PubMed ID: 37095619
[TBL] [Abstract][Full Text] [Related]
4. CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.
Wen M; Ren H; Zhang S; Li T; Zhang J; Ren P
Cell Death Dis; 2021 Jun; 12(7):650. PubMed ID: 34172717
[TBL] [Abstract][Full Text] [Related]
5. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
Tang F; Tang S; Guo X; Yang C; Jia K
Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
[TBL] [Abstract][Full Text] [Related]
6. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
Yang F; Li L; Zhang J; Zhang J; Yang L
Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
[TBL] [Abstract][Full Text] [Related]
7. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
[TBL] [Abstract][Full Text] [Related]
10. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
11. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
13. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway.
Yang P; Su C; Luo X; Zeng H; Zhao L; Wei L; Zhang X; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Cancer Lett; 2018 Dec; 438():76-85. PubMed ID: 30213558
[TBL] [Abstract][Full Text] [Related]
14. PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
Ma H; Han F; Yan X; Qi G; Li Y; Li R; Yan S; Yuan C; Song K; Kong B
J Cell Physiol; 2021 Apr; 236(4):2767-2781. PubMed ID: 33184870
[TBL] [Abstract][Full Text] [Related]
15. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells.
Kong L; Deng Z; Zhao Y; Wang Y; Sarkar FH; Zhang Y
Med Oncol; 2011 Dec; 28(4):1495-506. PubMed ID: 20532678
[TBL] [Abstract][Full Text] [Related]
18. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF
J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958
[TBL] [Abstract][Full Text] [Related]
20. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
